v3.26.1
Equity Method Investment (Tables)
12 Months Ended
Dec. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investment

The following summarizes the Company’ consolidated balance sheet equity method investment as follows (in thousands):

 

   Carrying Amount 
December 31, 2024, carrying amount  $41,764 
Portion of loss from eXoZymes   (4,282)
Gain related to dilution events   61 
December 31, 2025, carrying amount  $37,543